Filing Details

Accession Number:
0001209191-21-011620
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-17 21:34:41
Reporting Period:
2021-02-16
Accepted Time:
2021-02-17 21:34:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367920 Concert Pharmaceuticals Inc. CNCE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1594774 Nancy Stuart C/O Concert Pharmaceuticals, Inc.
65 Hayden Avenue, Suite 3000N
Lexington MA 02421
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-16 6,049 $7.32 173,280 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan entered into on November 11, 2020.
  2. These shares were sold to satisfy tax obligations associated with the vesting of restricted stock units.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.22 to $7.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.